Royal Bank of Canada »

Lava Therapeutics Nv shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Lava Therapeutics Nv (LVTX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Lava Therapeutics Nv

Tip: Access up to 7 years of quarterly data

All positions including Lava Therapeutics Nv held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lava Therapeutics Nv by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $69k 44k 1.56

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Lava Therapeutics Nv

Shay Capital
Redmile Group
BML Capital Management
Sanofi
Merck & Co
Gts Securities
Rangeley Capital
Susquehanna International
Pnc Financial Services
Citadel Advisors
Royal Bank of Canada
Lepercq De Neuflize Asset Management
Equitec Proprietary Markets
JBF Capital
XTX Topco

View all funds holding Lava Therapeutics Nv